Request for Covid-19 Impact Assessment of this Report
The United States Luteinizing Hormone-releasing Hormone Analogs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Luteinizing Hormone-releasing Hormone Analogs market, reaching US$ million by the year 2028. As for the Europe Luteinizing Hormone-releasing Hormone Analogs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Luteinizing Hormone-releasing Hormone Analogs players cover AbbVie, AstraZeneca, Ferring, and TerSera Therapeutics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Luteinizing Hormone-releasing Hormone Analogs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Leuprorelin
Goserelin
Taltirelin
Histrelin
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Pharmacy
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
AbbVie
AstraZeneca
Ferring
TerSera Therapeutics
Takeda
LIVZON
Ipsen
Sanofi
Endo
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Luteinizing Hormone-releasing Hormone Analogs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Luteinizing Hormone-releasing Hormone Analogs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Luteinizing Hormone-releasing Hormone Analogs by Country/Region, 2017, 2022 & 2028
2.2 Luteinizing Hormone-releasing Hormone Analogs Segment by Type
2.2.1 Leuprorelin
2.2.2 Goserelin
2.2.3 Taltirelin
2.2.4 Histrelin
2.2.5 Other
2.3 Luteinizing Hormone-releasing Hormone Analogs Sales by Type
2.3.1 Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Type (2017-2022)
2.3.2 Global Luteinizing Hormone-releasing Hormone Analogs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Luteinizing Hormone-releasing Hormone Analogs Sale Price by Type (2017-2022)
2.4 Luteinizing Hormone-releasing Hormone Analogs Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.4.3 Other
2.5 Luteinizing Hormone-releasing Hormone Analogs Sales by Application
2.5.1 Global Luteinizing Hormone-releasing Hormone Analogs Sale Market Share by Application (2017-2022)
2.5.2 Global Luteinizing Hormone-releasing Hormone Analogs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Luteinizing Hormone-releasing Hormone Analogs Sale Price by Application (2017-2022)
3 Global Luteinizing Hormone-releasing Hormone Analogs by Company
3.1 Global Luteinizing Hormone-releasing Hormone Analogs Breakdown Data by Company
3.1.1 Global Luteinizing Hormone-releasing Hormone Analogs Annual Sales by Company (2020-2022)
3.1.2 Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Company (2020-2022)
3.2 Global Luteinizing Hormone-releasing Hormone Analogs Annual Revenue by Company (2020-2022)
3.2.1 Global Luteinizing Hormone-releasing Hormone Analogs Revenue by Company (2020-2022)
3.2.2 Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Company (2020-2022)
3.3 Global Luteinizing Hormone-releasing Hormone Analogs Sale Price by Company
3.4 Key Manufacturers Luteinizing Hormone-releasing Hormone Analogs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Luteinizing Hormone-releasing Hormone Analogs Product Location Distribution
3.4.2 Players Luteinizing Hormone-releasing Hormone Analogs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Luteinizing Hormone-releasing Hormone Analogs by Geographic Region
4.1 World Historic Luteinizing Hormone-releasing Hormone Analogs Market Size by Geographic Region (2017-2022)
4.1.1 Global Luteinizing Hormone-releasing Hormone Analogs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Luteinizing Hormone-releasing Hormone Analogs Annual Revenue by Geographic Region
4.2 World Historic Luteinizing Hormone-releasing Hormone Analogs Market Size by Country/Region (2017-2022)
4.2.1 Global Luteinizing Hormone-releasing Hormone Analogs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Luteinizing Hormone-releasing Hormone Analogs Annual Revenue by Country/Region
4.3 Americas Luteinizing Hormone-releasing Hormone Analogs Sales Growth
4.4 APAC Luteinizing Hormone-releasing Hormone Analogs Sales Growth
4.5 Europe Luteinizing Hormone-releasing Hormone Analogs Sales Growth
4.6 Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Sales Growth
5 Americas
5.1 Americas Luteinizing Hormone-releasing Hormone Analogs Sales by Country
5.1.1 Americas Luteinizing Hormone-releasing Hormone Analogs Sales by Country (2017-2022)
5.1.2 Americas Luteinizing Hormone-releasing Hormone Analogs Revenue by Country (2017-2022)
5.2 Americas Luteinizing Hormone-releasing Hormone Analogs Sales by Type
5.3 Americas Luteinizing Hormone-releasing Hormone Analogs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Luteinizing Hormone-releasing Hormone Analogs Sales by Region
6.1.1 APAC Luteinizing Hormone-releasing Hormone Analogs Sales by Region (2017-2022)
6.1.2 APAC Luteinizing Hormone-releasing Hormone Analogs Revenue by Region (2017-2022)
6.2 APAC Luteinizing Hormone-releasing Hormone Analogs Sales by Type
6.3 APAC Luteinizing Hormone-releasing Hormone Analogs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Luteinizing Hormone-releasing Hormone Analogs by Country
7.1.1 Europe Luteinizing Hormone-releasing Hormone Analogs Sales by Country (2017-2022)
7.1.2 Europe Luteinizing Hormone-releasing Hormone Analogs Revenue by Country (2017-2022)
7.2 Europe Luteinizing Hormone-releasing Hormone Analogs Sales by Type
7.3 Europe Luteinizing Hormone-releasing Hormone Analogs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs by Country
8.1.1 Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Revenue by Country (2017-2022)
8.2 Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Sales by Type
8.3 Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Luteinizing Hormone-releasing Hormone Analogs
10.3 Manufacturing Process Analysis of Luteinizing Hormone-releasing Hormone Analogs
10.4 Industry Chain Structure of Luteinizing Hormone-releasing Hormone Analogs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Luteinizing Hormone-releasing Hormone Analogs Distributors
11.3 Luteinizing Hormone-releasing Hormone Analogs Customer
12 World Forecast Review for Luteinizing Hormone-releasing Hormone Analogs by Geographic Region
12.1 Global Luteinizing Hormone-releasing Hormone Analogs Market Size Forecast by Region
12.1.1 Global Luteinizing Hormone-releasing Hormone Analogs Forecast by Region (2023-2028)
12.1.2 Global Luteinizing Hormone-releasing Hormone Analogs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Luteinizing Hormone-releasing Hormone Analogs Forecast by Type
12.7 Global Luteinizing Hormone-releasing Hormone Analogs Forecast by Application
13 Key Players Analysis
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie Luteinizing Hormone-releasing Hormone Analogs Product Offered
13.1.3 AbbVie Luteinizing Hormone-releasing Hormone Analogs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca Luteinizing Hormone-releasing Hormone Analogs Product Offered
13.2.3 AstraZeneca Luteinizing Hormone-releasing Hormone Analogs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Ferring
13.3.1 Ferring Company Information
13.3.2 Ferring Luteinizing Hormone-releasing Hormone Analogs Product Offered
13.3.3 Ferring Luteinizing Hormone-releasing Hormone Analogs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Ferring Main Business Overview
13.3.5 Ferring Latest Developments
13.4 TerSera Therapeutics
13.4.1 TerSera Therapeutics Company Information
13.4.2 TerSera Therapeutics Luteinizing Hormone-releasing Hormone Analogs Product Offered
13.4.3 TerSera Therapeutics Luteinizing Hormone-releasing Hormone Analogs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 TerSera Therapeutics Main Business Overview
13.4.5 TerSera Therapeutics Latest Developments
13.5 Takeda
13.5.1 Takeda Company Information
13.5.2 Takeda Luteinizing Hormone-releasing Hormone Analogs Product Offered
13.5.3 Takeda Luteinizing Hormone-releasing Hormone Analogs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Takeda Main Business Overview
13.5.5 Takeda Latest Developments
13.6 LIVZON
13.6.1 LIVZON Company Information
13.6.2 LIVZON Luteinizing Hormone-releasing Hormone Analogs Product Offered
13.6.3 LIVZON Luteinizing Hormone-releasing Hormone Analogs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 LIVZON Main Business Overview
13.6.5 LIVZON Latest Developments
13.7 Ipsen
13.7.1 Ipsen Company Information
13.7.2 Ipsen Luteinizing Hormone-releasing Hormone Analogs Product Offered
13.7.3 Ipsen Luteinizing Hormone-releasing Hormone Analogs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Ipsen Main Business Overview
13.7.5 Ipsen Latest Developments
13.8 Sanofi
13.8.1 Sanofi Company Information
13.8.2 Sanofi Luteinizing Hormone-releasing Hormone Analogs Product Offered
13.8.3 Sanofi Luteinizing Hormone-releasing Hormone Analogs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Sanofi Main Business Overview
13.8.5 Sanofi Latest Developments
13.9 Endo
13.9.1 Endo Company Information
13.9.2 Endo Luteinizing Hormone-releasing Hormone Analogs Product Offered
13.9.3 Endo Luteinizing Hormone-releasing Hormone Analogs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Endo Main Business Overview
13.9.5 Endo Latest Developments
14 Research Findings and Conclusion
Table 1. Luteinizing Hormone-releasing Hormone Analogs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Luteinizing Hormone-releasing Hormone Analogs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Leuprorelin
Table 4. Major Players of Goserelin
Table 5. Major Players of Taltirelin
Table 6. Major Players of Histrelin
Table 7. Major Players of Other
Table 8. Global Luteinizing Hormone-releasing Hormone Analogs Sales by Type (2017-2022) & (K Units)
Table 9. Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Type (2017-2022)
Table 10. Global Luteinizing Hormone-releasing Hormone Analogs Revenue by Type (2017-2022) & ($ million)
Table 11. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Type (2017-2022)
Table 12. Global Luteinizing Hormone-releasing Hormone Analogs Sale Price by Type (2017-2022) & (USD/Unit)
Table 13. Global Luteinizing Hormone-releasing Hormone Analogs Sales by Application (2017-2022) & (K Units)
Table 14. Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Application (2017-2022)
Table 15. Global Luteinizing Hormone-releasing Hormone Analogs Revenue by Application (2017-2022)
Table 16. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Application (2017-2022)
Table 17. Global Luteinizing Hormone-releasing Hormone Analogs Sale Price by Application (2017-2022) & (USD/Unit)
Table 18. Global Luteinizing Hormone-releasing Hormone Analogs Sales by Company (2020-2022) & (K Units)
Table 19. Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Company (2020-2022)
Table 20. Global Luteinizing Hormone-releasing Hormone Analogs Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Company (2020-2022)
Table 22. Global Luteinizing Hormone-releasing Hormone Analogs Sale Price by Company (2020-2022) & (USD/Unit)
Table 23. Key Manufacturers Luteinizing Hormone-releasing Hormone Analogs Producing Area Distribution and Sales Area
Table 24. Players Luteinizing Hormone-releasing Hormone Analogs Products Offered
Table 25. Luteinizing Hormone-releasing Hormone Analogs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Luteinizing Hormone-releasing Hormone Analogs Sales by Geographic Region (2017-2022) & (K Units)
Table 29. Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Share Geographic Region (2017-2022)
Table 30. Global Luteinizing Hormone-releasing Hormone Analogs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Luteinizing Hormone-releasing Hormone Analogs Sales by Country/Region (2017-2022) & (K Units)
Table 33. Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Country/Region (2017-2022)
Table 34. Global Luteinizing Hormone-releasing Hormone Analogs Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Luteinizing Hormone-releasing Hormone Analogs Sales by Country (2017-2022) & (K Units)
Table 37. Americas Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Country (2017-2022)
Table 38. Americas Luteinizing Hormone-releasing Hormone Analogs Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Country (2017-2022)
Table 40. Americas Luteinizing Hormone-releasing Hormone Analogs Sales by Type (2017-2022) & (K Units)
Table 41. Americas Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Type (2017-2022)
Table 42. Americas Luteinizing Hormone-releasing Hormone Analogs Sales by Application (2017-2022) & (K Units)
Table 43. Americas Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Application (2017-2022)
Table 44. APAC Luteinizing Hormone-releasing Hormone Analogs Sales by Region (2017-2022) & (K Units)
Table 45. APAC Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Region (2017-2022)
Table 46. APAC Luteinizing Hormone-releasing Hormone Analogs Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Region (2017-2022)
Table 48. APAC Luteinizing Hormone-releasing Hormone Analogs Sales by Type (2017-2022) & (K Units)
Table 49. APAC Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Type (2017-2022)
Table 50. APAC Luteinizing Hormone-releasing Hormone Analogs Sales by Application (2017-2022) & (K Units)
Table 51. APAC Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Application (2017-2022)
Table 52. Europe Luteinizing Hormone-releasing Hormone Analogs Sales by Country (2017-2022) & (K Units)
Table 53. Europe Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Country (2017-2022)
Table 54. Europe Luteinizing Hormone-releasing Hormone Analogs Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Country (2017-2022)
Table 56. Europe Luteinizing Hormone-releasing Hormone Analogs Sales by Type (2017-2022) & (K Units)
Table 57. Europe Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Type (2017-2022)
Table 58. Europe Luteinizing Hormone-releasing Hormone Analogs Sales by Application (2017-2022) & (K Units)
Table 59. Europe Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Sales by Country (2017-2022) & (K Units)
Table 61. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Sales by Type (2017-2022) & (K Units)
Table 65. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Sales by Application (2017-2022) & (K Units)
Table 67. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Luteinizing Hormone-releasing Hormone Analogs
Table 69. Key Market Challenges & Risks of Luteinizing Hormone-releasing Hormone Analogs
Table 70. Key Industry Trends of Luteinizing Hormone-releasing Hormone Analogs
Table 71. Luteinizing Hormone-releasing Hormone Analogs Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Luteinizing Hormone-releasing Hormone Analogs Distributors List
Table 74. Luteinizing Hormone-releasing Hormone Analogs Customer List
Table 75. Global Luteinizing Hormone-releasing Hormone Analogs Sales Forecast by Region (2023-2028) & (K Units)
Table 76. Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Forecast by Region
Table 77. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Luteinizing Hormone-releasing Hormone Analogs Sales Forecast by Country (2023-2028) & (K Units)
Table 80. Americas Luteinizing Hormone-releasing Hormone Analogs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Luteinizing Hormone-releasing Hormone Analogs Sales Forecast by Region (2023-2028) & (K Units)
Table 82. APAC Luteinizing Hormone-releasing Hormone Analogs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Luteinizing Hormone-releasing Hormone Analogs Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Europe Luteinizing Hormone-releasing Hormone Analogs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Luteinizing Hormone-releasing Hormone Analogs Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Luteinizing Hormone-releasing Hormone Analogs Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share Forecast by Application (2023-2028)
Table 95. AbbVie Basic Information, Luteinizing Hormone-releasing Hormone Analogs Manufacturing Base, Sales Area and Its Competitors
Table 96. AbbVie Luteinizing Hormone-releasing Hormone Analogs Product Offered
Table 97. AbbVie Luteinizing Hormone-releasing Hormone Analogs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 98. AbbVie Main Business
Table 99. AbbVie Latest Developments
Table 100. AstraZeneca Basic Information, Luteinizing Hormone-releasing Hormone Analogs Manufacturing Base, Sales Area and Its Competitors
Table 101. AstraZeneca Luteinizing Hormone-releasing Hormone Analogs Product Offered
Table 102. AstraZeneca Luteinizing Hormone-releasing Hormone Analogs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 103. AstraZeneca Main Business
Table 104. AstraZeneca Latest Developments
Table 105. Ferring Basic Information, Luteinizing Hormone-releasing Hormone Analogs Manufacturing Base, Sales Area and Its Competitors
Table 106. Ferring Luteinizing Hormone-releasing Hormone Analogs Product Offered
Table 107. Ferring Luteinizing Hormone-releasing Hormone Analogs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 108. Ferring Main Business
Table 109. Ferring Latest Developments
Table 110. TerSera Therapeutics Basic Information, Luteinizing Hormone-releasing Hormone Analogs Manufacturing Base, Sales Area and Its Competitors
Table 111. TerSera Therapeutics Luteinizing Hormone-releasing Hormone Analogs Product Offered
Table 112. TerSera Therapeutics Luteinizing Hormone-releasing Hormone Analogs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 113. TerSera Therapeutics Main Business
Table 114. TerSera Therapeutics Latest Developments
Table 115. Takeda Basic Information, Luteinizing Hormone-releasing Hormone Analogs Manufacturing Base, Sales Area and Its Competitors
Table 116. Takeda Luteinizing Hormone-releasing Hormone Analogs Product Offered
Table 117. Takeda Luteinizing Hormone-releasing Hormone Analogs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 118. Takeda Main Business
Table 119. Takeda Latest Developments
Table 120. LIVZON Basic Information, Luteinizing Hormone-releasing Hormone Analogs Manufacturing Base, Sales Area and Its Competitors
Table 121. LIVZON Luteinizing Hormone-releasing Hormone Analogs Product Offered
Table 122. LIVZON Luteinizing Hormone-releasing Hormone Analogs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 123. LIVZON Main Business
Table 124. LIVZON Latest Developments
Table 125. Ipsen Basic Information, Luteinizing Hormone-releasing Hormone Analogs Manufacturing Base, Sales Area and Its Competitors
Table 126. Ipsen Luteinizing Hormone-releasing Hormone Analogs Product Offered
Table 127. Ipsen Luteinizing Hormone-releasing Hormone Analogs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 128. Ipsen Main Business
Table 129. Ipsen Latest Developments
Table 130. Sanofi Basic Information, Luteinizing Hormone-releasing Hormone Analogs Manufacturing Base, Sales Area and Its Competitors
Table 131. Sanofi Luteinizing Hormone-releasing Hormone Analogs Product Offered
Table 132. Sanofi Luteinizing Hormone-releasing Hormone Analogs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 133. Sanofi Main Business
Table 134. Sanofi Latest Developments
Table 135. Endo Basic Information, Luteinizing Hormone-releasing Hormone Analogs Manufacturing Base, Sales Area and Its Competitors
Table 136. Endo Luteinizing Hormone-releasing Hormone Analogs Product Offered
Table 137. Endo Luteinizing Hormone-releasing Hormone Analogs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 138. Endo Main Business
Table 139. Endo Latest Developments
List of Figures
Figure 1. Picture of Luteinizing Hormone-releasing Hormone Analogs
Figure 2. Luteinizing Hormone-releasing Hormone Analogs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Luteinizing Hormone-releasing Hormone Analogs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Luteinizing Hormone-releasing Hormone Analogs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Leuprorelin
Figure 10. Product Picture of Goserelin
Figure 11. Product Picture of Taltirelin
Figure 12. Product Picture of Histrelin
Figure 13. Product Picture of Other
Figure 14. Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Type in 2021
Figure 15. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Type (2017-2022)
Figure 16. Luteinizing Hormone-releasing Hormone Analogs Consumed in Hospital
Figure 17. Global Luteinizing Hormone-releasing Hormone Analogs Market: Hospital (2017-2022) & (K Units)
Figure 18. Luteinizing Hormone-releasing Hormone Analogs Consumed in Pharmacy
Figure 19. Global Luteinizing Hormone-releasing Hormone Analogs Market: Pharmacy (2017-2022) & (K Units)
Figure 20. Luteinizing Hormone-releasing Hormone Analogs Consumed in Other
Figure 21. Global Luteinizing Hormone-releasing Hormone Analogs Market: Other (2017-2022) & (K Units)
Figure 22. Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Application (2017-2022)
Figure 23. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Application in 2021
Figure 24. Luteinizing Hormone-releasing Hormone Analogs Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Company in 2021
Figure 26. Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Geographic Region in 2021
Figure 28. Global Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Region (2017-2022)
Figure 29. Global Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Country/Region in 2021
Figure 30. Americas Luteinizing Hormone-releasing Hormone Analogs Sales 2017-2022 (K Units)
Figure 31. Americas Luteinizing Hormone-releasing Hormone Analogs Revenue 2017-2022 ($ Millions)
Figure 32. APAC Luteinizing Hormone-releasing Hormone Analogs Sales 2017-2022 (K Units)
Figure 33. APAC Luteinizing Hormone-releasing Hormone Analogs Revenue 2017-2022 ($ Millions)
Figure 34. Europe Luteinizing Hormone-releasing Hormone Analogs Sales 2017-2022 (K Units)
Figure 35. Europe Luteinizing Hormone-releasing Hormone Analogs Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Sales 2017-2022 (K Units)
Figure 37. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Revenue 2017-2022 ($ Millions)
Figure 38. Americas Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Country in 2021
Figure 39. Americas Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Country in 2021
Figure 40. United States Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Region in 2021
Figure 45. APAC Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Regions in 2021
Figure 46. China Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Country in 2021
Figure 53. Europe Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Country in 2021
Figure 54. Germany Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Luteinizing Hormone-releasing Hormone Analogs Revenue Market Share by Country in 2021
Figure 61. Egypt Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Luteinizing Hormone-releasing Hormone Analogs Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Luteinizing Hormone-releasing Hormone Analogs in 2021
Figure 67. Manufacturing Process Analysis of Luteinizing Hormone-releasing Hormone Analogs
Figure 68. Industry Chain Structure of Luteinizing Hormone-releasing Hormone Analogs
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...